The basic principle of infection prevention and control is hygiene. Infection control (WHO) ensures the protection against acquiring an infection both in the general community and while receiving care due to health problems, in a range of settings. Biosafety addresses the safe handling and containment of infectious microorganisms and hazardous biological materials. Biosafety utilizes a combination of risk assessment and containment principles to reduce or prevent exposures to research personnel working with infectious agents (CDC and NIH). While the overall goal of biosafety and infection control is containment of the pathogen, mainly focused on reducing the spread of disease; whereas, in biosafety, the focus is on containing the infectious organism during research so the worker or environment does not become infected or contaminated. Infection control in hospitals deals with improving patients’ safety and combating infections, whereas biosafety deals with recognizing the intrinsic hazards of potentially pathogenic organisms, categorizing them according to risk assessments and implementing barriers that prevent acquisition of these pathogens while handling them. Biological safety also refers to the safe handling of biological materials by means of techniques, equipment and containment conditions to prevent personal, laboratory and environmental exposure to potentially infectious agents or biohazards.
The global infection control and biosafety products market segmentation is based on product type (healthcare-associated infection (HAI) prevention products and services – medical waste disposal products and services, single-patient-use medical device reprocessing services, automated patient surveillance systems; injection devices and related products – skin puncture devices, standard disposable needles and syringes, safety needles and syringes, sharps disposal products; bacterial and viral diagnostic products – bacterial infectious disease diagnosis, viral infectious disease diagnosis; sterilization equipment, services, and supplies – sterilization equipment, sterilization services, sterilization supplies).
The global infection control and biosafety products market research report provides market size (Revenue USD Million 2014 to 2021), market share analysis, growth trends and forecast (CAGR%, 2017 to 2021). The global infection control and biosafety products market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. In addition, the global infection control and biosafety products market report provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis, and market profitability analysis by key products and regions or countries. The report also tracks the major competitors operating in the global market by company overview, financial snapshot, major products, technologies, services offered and recent developments.
Major players operating in the global infection control and biosafety products market and profiled in this report include 3M Health Care, Abbott Laboratories, Air-Tite Products Co., Inc., Alere, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Bemis Manufacturing Company, Bio-Rad Laboratories, Inc., Cepheid, Inc., ChemBio Diagnostics Systems, Inc., Cosmed Group, Inc., CR Bard, Inc., Custom Ultrasonics, Inc., Diaxonhit SA, EuroClone SPA, Euroimmun AG, Genekam Biotechnology AG, Getinge Group, Halyard Health, Inc., Hologic, Inc., Hygia Health Services, Inc., Innovative Health, Inc., Johnson & Johnson, Medline Industries, Inc., Medtronic PLC, Meridian Bioscience, Inc., Mesa Labs, Inc., Metall Zug Group, Nipro Medical Corporation, OraSure Technologies, Inc., Oxford Immunotec, Inc., Primerdesign LTD, Qiagen, Inc., Quest Diagnostics, Inc., Quidel Corporation, Retractable Technologies, Inc., RL Solutions, Roche Diagnostics, Sharps Compliance, Inc., Siemens Healthineers, Smiths Medical, Stericycle, Inc., Sterigenics International LLC, Sterilmed, Inc., STERIS Corporation, Stryker Corporation, TheraDoc, Inc. (Premier, Inc.), Thermo Fisher Scientific, Inc., Trinity Biotech PLC, TSO3, Inc., US Medical Instruments, Inc., Vanguard AG, Vela Diagnostics LTD, and Waste Management, Inc.